DANSK FARMACEUTISK INDUSTRI A/S — Credit Rating and Financial Key Figures
CVR number: 10224675
Dam Enge 4, 3660 Stenløse
dfi@dkpharma.dk
tel: 44860550
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 11 419.74 | 20 799.04 | 15 590.63 | 12 266.48 | 18 406.38 |
| Employee benefit expenses | -3 900.74 | -3 526.64 | -4 561.26 | -5 383.77 | -3 556.32 |
| Other operating expenses | -29.14 | - 153.80 | - 219.78 | ||
| Total depreciation | - 510.20 | - 339.97 | - 215.89 | - 175.14 | - 141.74 |
| EBIT | 7 008.80 | 16 903.29 | 10 659.67 | 6 487.80 | 14 708.33 |
| Other financial income | 102.97 | 53.59 | 188.77 | 1 339.46 | 2 386.93 |
| Other financial expenses | -81.39 | - 146.81 | -1 457.14 | -1 637.12 | -2 750.17 |
| Pre-tax profit | 7 030.38 | 16 810.07 | 9 391.30 | 6 190.14 | 14 345.10 |
| Income taxes | -1 548.45 | -3 701.58 | -2 074.87 | -1 368.20 | -3 159.28 |
| Net earnings | 5 481.93 | 13 108.48 | 7 316.43 | 4 821.94 | 11 185.81 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Buildings | 29.02 | 10.19 | |||
| Machinery and equipment | 1 850.77 | 1 144.99 | 353.26 | 178.12 | 36.38 |
| Tangible assets total | 1 879.79 | 1 155.18 | 353.26 | 178.12 | 36.38 |
| Holdings in group member companies | 40.00 | 40.00 | |||
| Other receivables | 543.62 | 564.01 | 564.01 | 580.80 | 632.47 |
| Investments total | 583.62 | 604.01 | 564.01 | 580.80 | 632.47 |
| Long term receivables total | |||||
| Raw materials and consumables | 3 596.11 | 3 236.72 | 6 327.37 | 6 677.30 | 2 788.66 |
| Finished products/goods | 4 554.41 | 3 714.27 | 5 505.38 | 3 484.54 | 6 122.80 |
| Advance payments | 377.48 | 810.11 | 788.91 | 474.77 | 280.98 |
| Inventories total | 8 528.01 | 7 761.10 | 12 621.66 | 10 636.61 | 9 192.44 |
| Current trade debtors | 8 682.29 | 8 403.81 | 9 812.33 | 8 524.48 | 10 406.67 |
| Current amounts owed by group member comp. | 3 224.39 | 13 178.14 | 17 170.42 | 17 087.32 | 2 452.82 |
| Prepayments and accrued income | 133.06 | 590.69 | 46.53 | 253.92 | 209.61 |
| Current other receivables | 2 977.76 | 3 005.95 | 2 870.47 | 444.85 | 764.23 |
| Current deferred tax assets | 44.31 | 48.91 | |||
| Short term receivables total | 15 017.50 | 25 178.59 | 29 899.74 | 26 354.88 | 13 882.24 |
| Other current investments | 862.56 | 0.17 | 2 355.06 | 1 131.48 | |
| Cash and bank deposits | 2 075.00 | 1 111.53 | 37.68 | 10 928.15 | |
| Cash and cash equivalents | 2 937.56 | 1 111.70 | 2 392.74 | 12 059.63 | |
| Balance sheet total (assets) | 28 946.48 | 35 810.58 | 45 831.41 | 49 810.04 | 23 743.54 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 2 400.00 | 2 400.00 | 2 400.00 | 2 400.00 | 2 400.00 |
| Shares repurchased | 5 500.00 | 13 300.00 | 8 000.00 | 5 000.00 | 10 000.00 |
| Retained earnings | -4 372.56 | -12 190.63 | -7 082.15 | -4 765.72 | -9 943.78 |
| Profit of the financial year | 5 481.93 | 13 108.48 | 7 316.43 | 4 821.94 | 11 185.81 |
| Shareholders equity total | 9 009.37 | 16 617.85 | 10 634.28 | 7 456.22 | 13 642.03 |
| Provisions | 113.21 | 196.28 | 18.41 | ||
| Non-current deferred tax liabilities | 1 548.23 | 3 617.77 | 2 252.40 | 1 430.92 | 3 163.89 |
| Non-current liabilities total | 1 548.23 | 3 617.77 | 2 252.40 | 1 430.92 | 3 163.89 |
| Current loans from credit institutions | 73.14 | 1 260.31 | 915.23 | ||
| Current trade creditors | 636.64 | 257.11 | 1 617.54 | 1 226.37 | 1 772.51 |
| Current owed to group member | 13 044.82 | 11 838.79 | 27 867.24 | 31 275.82 | |
| Short-term deferred tax liabilities | 2 252.53 | 1 430.92 | |||
| Other non-interest bearing current liabilities | 4 521.07 | 3 282.77 | 2 181.22 | 6 168.18 | 2 818.96 |
| Current liabilities total | 18 275.67 | 15 378.68 | 32 926.31 | 40 922.90 | 6 937.62 |
| Balance sheet total (liabilities) | 28 946.48 | 35 810.58 | 45 831.41 | 49 810.04 | 23 743.54 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.